Alpha Cognition agrees to pay EUR 5,214,220 to settle Galantos Memogain obligations
Alpha Cognition entered a settlement agreement dated April 10, 2026 with Galantos Pharma GmbH i.L., a company in liquidation, to extinguish future royalty and milestone payments under the Memogain Asset Purchase Agreement. In exchange for a one-time payment of EUR 5,214,220, Galantos agreed to release the company and its related parties from claims arising from the original agreement. The filing does not state the financial impact on the company's results.
Key points
- One-time payment of EUR 5,214,220 to Galantos in full satisfaction of remaining contingent obligations, including royalty and milestone-related payments.
- Galantos waives and releases the company and its related parties from causes of action arising from the Original Agreement.
- Management states the settlement is an approximate 40% discount to the estimated market value of the remaining obligations, based on its own projections and comparable market benchmarks.
- Agreement dated April 10, 2026; filed as Exhibit 10.1 to the report signed by CEO Michael McFadden on April 14, 2026.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 14, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.